 Flow cytometric studies human osteosarcoma number recent studies potential value flow cytometry marker malignity therefore biologic behavior neoplasms bone tumors propidium iodide home-built flow cytometer authors DNA distribution patients osteosarcoma percentage cells diploidy S-phase tetraploidy aneuploidy values derived DNA concentration possible extent abnormalities group neoplasms severity normal pattern data disease-free survival total survival correlations weak patterns predictive increased risk metastasis death effect treatment pattern chemotherapy survival likely improvement technology flow cytometry value future prognosis osteosarcoma treatment effective